Amyotrophic Lateral Sclerosis is categorized under Medical and Surgical Services Organizations in Columbus, OH and active since 1982.
Amyotrophic Lateral Sclerosis was established in 1982, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical and Surgical Services Organizations business, which does work in the B2C market, and is classified as a Medical and Surgical Services Organizations, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Mark Hollern at the company’s single location by writing to 299 East Kelso Road, Columbus, Ohio OH 43202 or by phoning (614) 261-4645. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amyotrophic Lateral Sclerosis |
| Contact Person: | Mark Hollern |
| Address: | 299 East Kelso Road, Columbus, Ohio 43202 |
| Phone Number: | (614) 261-4645 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical and Surgical Services Organizations |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Amyotrophic Lateral Sclerosis was started in 1982 to provide professional Medical and Surgical Services Organizations under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Hollern for inquiries that concern Amyotrophic Lateral Sclerosis by calling the company number (614) 261-4645, as your correspondence is most welcome. Additionally, the physical location of the single location of Amyotrophic Lateral Sclerosis can be found at the coordinates 40.0212,-83.004736 as well as the street address 299 East Kelso Road in Columbus, Ohio 43202.
For its online presence, you may visit Amyotrophic Lateral Sclerosis’s website at and engage with its social media outlets through on Twitter and on Facebook.